Literature DB >> 27265076

Pemphigoid gestationis: Toward a better understanding of the etiopathogenesis.

Christian D Sadik1, Ana L Lima2, Detlef Zillikens2.   

Abstract

Pemphigoid gestationis (PG) is the only autoimmune disease exclusively emerging in pregnancy. It belongs to the pemphigoid group of disorders, a class of autoimmune blistering skin diseases featuring an immune response against different hemidesmosomal proteins. PG is caused by a break of immunotolerance against the hemidesmosomal protein BP180. Several lines of evidence suggest that this break of immunotolerance is linked to specific maternal major histocompatibility complex (MHC) class II gene variants and aberrant expression of MHC class II molecules in the placenta. The close time association of the emergence of PG with pregnancy and the obviously very short period required from the initial break of immunotolerance to the onset of skin inflammation set PG into a unique position among autoimmune diseases in view of the fact that, for other autoimmune diseases, the time and site of the break of immunotolerance are usually vastly elusive and the period of silent disease can only be speculated on. In this review we highlight the features of PG and summarize current knowledge about its pathogenesis. We believe that this disease offers the best opportunity to elucidate comprehensively all phases of the pathogenesis of an autoantibody-driven disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27265076     DOI: 10.1016/j.clindermatol.2016.02.010

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  10 in total

1.  Pemphigoid gestationis successfully treated with intravenous immunoglobulin.

Authors:  Filipa Tavares Almeida; Rita Sarabando; Joana Pardal; Celeste Brito
Journal:  BMJ Case Rep       Date:  2018-04-07

Review 2.  [Specific dermatoses of pregnancy].

Authors:  C M Ambros-Rudolph; M Sticherling
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  [32-year-old female, pregnant and with pruritic rash : Preparation for the medical specialist examination: Part 4].

Authors:  Falk Ochsendorf
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  [Pemphigoid gestationis after egg donation : A case report].

Authors:  E Oms; M Tronnier
Journal:  Hautarzt       Date:  2020-03       Impact factor: 0.751

Review 6.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers.

Authors:  Christian D Sadik; Ewan A Langan; Ralf Gutzmer; Maria Isabel Fleischer; Carmen Loquai; Lydia Reinhardt; Friedegund Meier; Daniela Göppner; Rudolf A Herbst; Detlef Zillikens; Patrick Terheyden
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561

Review 8.  Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes.

Authors:  A Razzaque Ahmed; Sarah Anwar; Pedro A Reche
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

Review 9.  Diagnostics of autoimmune blistering disorders: an experience of a single tertiary referral centre.

Authors:  Alicja Adaszewska; Katarzyna Woźniak; Agnieszka Kalińska-Bienias; Katarzyna Smolarczyk; Cezary Kowalewski
Journal:  Postepy Dermatol Alergol       Date:  2020-11-04       Impact factor: 1.664

10.  Pemphigoid gestationis: Clinical and histologic features of twenty-three patients.

Authors:  Z Hallaji; H Mortazavi; S Ashtari; A Nikoo; M Abdollahi; M Nasimi
Journal:  Int J Womens Dermatol       Date:  2016-12-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.